2009 Annual Report: Shandong Pharmaceutical Glass

Date: 25 March 2010
Source: Tradingmarkets.com
The following is a table showing the main business indicators for 2009 of Shanghai-listed Shandong Pharmaceutical Glass Co.

Ltd. (600529.SH): 2009/adjusted 2008/adjusted Earnings per share (yuan) 0.56/0.57 0.53/0.47 Net assets per share (yuan) 6.18 5.65 Return on net assets (pct) 9.5 9.77 Net cash flow (yuan) 0.97 0.36 Main operating turnover (million yuan) 1242.1585 1158.2921 Net profit attributable to group (million yuan) 144.3619(147.8822) 135.1625 Distribution plan 0.1 yuan cash dividend per share (Tax included)
Read more here.

600450 2009 Annual Report: Shandong Pharmaceutical Glass glassonweb.com
Date: 25 March 2010
Source: Tradingmarkets.com

See more news about:

See more from these topics:

Others also read

LandGlass is going to attend FC 2016 to share its cutting-edge LandVac tempered vacuum insulated glass with the professionals in the glass industry.
For the first time, LandGlass presented both of its core products.
AluK will showcase its superior, top-level products, and share its expertise in the field of windows and doors.
China Ginza Tokyo is a luxurious and unique building expressing the spirit of Chanel through a façade generating images and acting as lighting for the building.
Moen Glass PTY LTD, based in Victoria, Australia, was incorporated in 1984. It is a family owned manufacturing company, dedicated to servicing the glass and window industries throughout Australia.
China’s largest glass manufacturer is planning to raise its investment in Malaysia by 100% to US$400mil (RM1.6bil) and to set up its overseas headquarters in Kuala Lumpur, group chairman Ge Wenyao told visiting Malaysian minister Datuk Seri Ong Ka Chuan.

From industry

Add new comment